tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

OLMA Stock Latest News

Olema Pharmaceuticals Advances Phase 1 Study of OP-3136 for Advanced Tumors
Company AnnouncementsOlema Pharmaceuticals Advances Phase 1 Study of OP-3136 for Advanced Tumors
2d ago
OLMA
Olema Pharmaceuticals’ New Study on Advanced Breast Cancer Treatment: A Potential Game-Changer?
PremiumCompany Announcements
Olema Pharmaceuticals’ New Study on Advanced Breast Cancer Treatment: A Potential Game-Changer?
2d ago
OLMA
Olema Pharmaceuticals’ Phase 3 Study: A New Hope for Advanced Breast Cancer Treatment
PremiumCompany Announcements
Olema Pharmaceuticals’ Phase 3 Study: A New Hope for Advanced Breast Cancer Treatment
2d ago
OLMA
Promising Outlook for Olema Pharmaceuticals: Buy Rating Driven by Palazestrant’s Potential in Breast Cancer Treatment
PremiumRatings
Promising Outlook for Olema Pharmaceuticals: Buy Rating Driven by Palazestrant’s Potential in Breast Cancer Treatment
2d ago
OLMA
JPMorgan healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
JPMorgan healthcare analysts hold an analyst/industry conference call
6d ago
OLMA
Olema Pharmaceuticals Reports Positive Phase 1b/2 Trial Results
PremiumCompany AnnouncementsOlema Pharmaceuticals Reports Positive Phase 1b/2 Trial Results
9d ago
8K
OLMA
Midday Fly By: AWS hit by outage, Kering sells beauty unit
Premium
The Fly
Midday Fly By: AWS hit by outage, Kering sells beauty unit
9d ago
BA
DX
Morning Movers: Cleveland-Cliffs surges following earnings report
Premium
The Fly
Morning Movers: Cleveland-Cliffs surges following earnings report
9d ago
CLF
COO
Promising Potential of Olema Pharmaceuticals’ Palazestrant in ER+/HER- Metastatic Breast Cancer Treatment: An Analyst’s Buy Recommendation
PremiumRatings
Promising Potential of Olema Pharmaceuticals’ Palazestrant in ER+/HER- Metastatic Breast Cancer Treatment: An Analyst’s Buy Recommendation
9d ago
OLMA
Oppenheimer remains bullish on Olema despite ‘Jekyll and Hyde kinda ESMO’
PremiumThe Fly
Oppenheimer remains bullish on Olema despite ‘Jekyll and Hyde kinda ESMO’
9d ago
CHRO
OLMA
Promising Efficacy and Safety of Olema Pharmaceuticals’ Palazestrant in Metastatic Breast Cancer Trials Supports Buy Rating
PremiumRatings
Promising Efficacy and Safety of Olema Pharmaceuticals’ Palazestrant in Metastatic Breast Cancer Trials Supports Buy Rating
9d ago
OLMA
Olema announces updated data on Phase 1b/2 study of palazestrant, ribociclib
PremiumThe Fly
Olema announces updated data on Phase 1b/2 study of palazestrant, ribociclib
10d ago
OLMA
Olema Oncology initiated with a Buy at Guggenheim
PremiumThe FlyOlema Oncology initiated with a Buy at Guggenheim
21d ago
OLMA
Promising Potential of Olema Pharmaceuticals’ Palazestrant in ESR1 Patient Treatment Drives Buy Rating
Premium
Ratings
Promising Potential of Olema Pharmaceuticals’ Palazestrant in ESR1 Patient Treatment Drives Buy Rating
1M ago
OLMA
Oppenheimer reiterates Buy on Olema, sees evERA readthrough to persevERA
Premium
The Fly
Oppenheimer reiterates Buy on Olema, sees evERA readthrough to persevERA
1M ago
CHRO
OLMA
Oppenheimer reiterates Buy on Olema, sees evERA readthrough to persevERA
PremiumThe Fly
Oppenheimer reiterates Buy on Olema, sees evERA readthrough to persevERA
1M ago
CHRO
OLMA
Olema Pharmaceuticals: Strategic Positioning and Promising Outlook in the Oral SERD Market
PremiumRatings
Olema Pharmaceuticals: Strategic Positioning and Promising Outlook in the Oral SERD Market
1M ago
OLMA
Oppenheimer says Olema collaboration with Pfizer could lead to bidding war
PremiumThe Fly
Oppenheimer says Olema collaboration with Pfizer could lead to bidding war
2M ago
NVS
PFE
Buy Recommendation for Olema Pharmaceuticals Driven by Strategic Collaborations and Promising Clinical Developments
PremiumRatings
Buy Recommendation for Olema Pharmaceuticals Driven by Strategic Collaborations and Promising Clinical Developments
2M ago
OLMA
Strategic Collaboration with Pfizer Boosts Olema Pharmaceuticals’ Prospects in ER+ Breast Cancer Treatment
PremiumRatingsStrategic Collaboration with Pfizer Boosts Olema Pharmaceuticals’ Prospects in ER+ Breast Cancer Treatment
2M ago
OLMA
Olema Pharmaceuticals Partners with Pfizer for New Trial
Premium
Company Announcements
Olema Pharmaceuticals Partners with Pfizer for New Trial
2M ago
8K
OLMA
Olema Oncology announces new trial agreement with Pfizer
Premium
The Fly
Olema Oncology announces new trial agreement with Pfizer
2M ago
PFE
OLMA

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >